BioNTech SE is flexible about its future structure as it prepares to bring a slew of cancer drugs to market, with its chief ...

Since the early stages of the COVID-19 vaccine rollout in the U.S., vaccine skeptics have used outdated interviews to spread claims that executives are refusing shots developed by their own ...

CLAIM: Video shows that the CEO of BioNTech, Dr. Ugur Sahin, will not take the COVID-19 vaccine that his firm developed with Pfizer. THE FACTS: Social media posts are misrepresenting an interview that ...

Side effects that have emerged in a large late-stage trial of a Covid-19 vaccine candidate from Pfizer Inc. and BioNTech SE are in line with those seen in smaller early studies, a positive sign for ...

Pfizer and BioNTech are confident they can have a vaccine against the novel coronavirus ready for regulatory approval by the middle of October or early November, BioNTech CEO and co-founder Ugur Sahin ...

The chief executive of Germany's BioNTech SE said the biggest challenge facing it and partner Pfizer Inc now that their COVID-19 vaccine is authorized for use in the United States will be to scale up ...

The various COVID-19 vaccines have been a game-changer for international pandemic. The Pfizer-BioNTech vaccine in particular was the first one to be approved for use in many countries. Axel Springer ...

BioNTech (BNTX) - the messenger-RNA pioneer that partnered with pharma giant Pfizer (PFE) on the Comirnaty COVID vaccine - announced its Q422 and FY22 earnings earlier today, as well as updating on ...